RDY
$42.09
Dr. Reddy's Laboratories
($.99)
(2.30%)
RDY
Earnings Whisper ®
N/A
4th Quarter March 2020
Consensus:  $0.00
Revenue:  N/A
Monday
Apr 27
4:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Monday, January 27, 2020

What do you expect when RDY reports earnings?
Beat
Meet
Miss

Where is RDY's stock price going from here?
Up
Flat
Down
Stock chart of RDY
Analysts
Summary of analysts' recommendations for RDY
Score
Grade
Pivots
Resistance
$43.79
$43.45
$42.77

$42.43

Support
$41.75
$41.41
$40.73
Tweet
Growth
Description
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection
Peers
Regeneron PharmaceuticalsBioMarin PharmaceuticalVertex PharmaceuticalsInterCeptJohnson & JohnsonMylanZoetisUltragenyx PharmaceuticalBristol-Myers SquibbAlkermes